Roche Holding AG - Net Income Applicable To Common Shares
Roche Holding AG's Fiscal Year is From January To December - All Figures are in CHF, Billions.
The item "Net-Income-Applicable-To-Common-Shares" stands at 9.43 Billion Swiss Francs for the trailing twelve months (TTM) period ending 06/30/2025.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -11.21 percent compared to the value the year prior.
The 1 year change in percent is -11.21.
The 3 year change in percent is -35.67.
The 5 year change in percent is -27.23.
The 10 year change in percent is -30.16.
The Serie's change in percent from it's minimum value, on 03/31/2024, to it's latest available value, on 06/30/2025, is +18.91%.
The Serie's change in percent from it's maximum value, on 12/31/2013, to it's latest available value, on 06/30/2025, is -43.69%.
Net Income Applicable To Common Shares for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | Eli Lilly and Company - Net Income Applicable To Common Shares | 905,699,262,464.00 |
 | Johnson & Johnson - Net Income Applicable To Common Shares | 486,508,953,600.00 |
 | AbbVie Inc - Net Income Applicable To Common Shares | 399,570,305,024.00 |
 | AstraZeneca PLC - Net Income Applicable To Common Shares | 280,205,508,085.11 |
 | Novartis AG - Net Income Applicable To Common Shares | 255,096,620,580.91 |